Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 7Phase 3 4Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Other neoplasm 1Breast 1

Conditions

Prostatic Neoplasms 3Precancerous Conditions 1Hot Flashes 1Breast Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Soybean Proteins × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT00064194 2020-04-03

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Canadian Cancer Trials Group

Phase 3 Completed
310 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

NCT00513916 2013-12-19

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

National Cancer Institute (NCI)

Phase 3 Completed
100 enrolled
Breast

Breast Neoplasms

NCT00003367 2013-06-26

Diet and PSA Levels in Patients With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
154 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡